22 results
Pain Assessment and Management Initiative (PAMI) - Non-Opioid Analgesics - Agents and Dosing

#Management #Pain #Pharmacology #NonOpioid
Pain Assessment ... and Management Initiative ... Non-Opioid Analgesics - Agents ... #Pain #Pharmacology ... NonOpioid #Analgesics #Medications
Pain Assessment and Management Initiative (PAMI) - Muscle Relaxants - Agents and Dosing

#Management #Pain #Pharmacology #Muscle
Pain Assessment ... and Management Initiative ... Muscle Relaxants - Agents ... #Pain #Pharmacology ... Relaxers #Relaxants #Medications
Pain Assessment and Management Initiative (PAMI) - Neuropathic Pain Medications:

Agent, Initiation Dose and Max Dosages

 -
and Management Initiative ... Medications: ... Agent, Initiation ... #Pain #Pharmacology ... #Neuropathic #Medications
Pain Assessment and Management Initiative (PAMI) - Nerve Blocks - Nerve Distribution, Agents and Dosing Table
Pain Assessment ... and Management Initiative ... Distribution, Agents ... #Pain #Pharmacology ... Nerve #Blocks #Medications
A quick infographic describing some of the common reversal agents used by anesthesiologists, their mechanism of
#management #anesthesia ... anesthesiology #treatment #medications ... References: Pani ... Pharmacology of ... neuromuscular pharmacology
Intern Pocket Cards - Pharmacologic Pain Management Options
Anti-inflammatory:
 • Acetaminophen (24 hours: < 3-4g in healthy
Pocket Cards - Pharmacologic ... Pain Management ... Table #Ladder #medications ... #pharmacology # ... agents #internship
Tranexamic Acid - Indications and Pharmacology
Pharmacokinetics:
 • MOA: Inhibits plasminogen activation to plasmin & inhibits fibrinolysis
and Pharmacology ... Hypotension with rapid injection ... diarrhea & abdominal pain ... arterial thrombotic events ... #Pharmacology #
Pain Assessment and Management Initiative (PAMI) - Intranasal and Nebulized Medications- Agents and Dosing

#Management #Pain #Pharmacology
Pain Assessment ... and Management Initiative ... - Agents and Dosing ... #Management # ... Pain #Pharmacology
Anti-IL6 Agents (Tocilizumab, Siltuximab) in COVID19

IL-6 activates T cells and macrophages, among other cell types (see
Anti-IL6 Agents ... respiratory tract infection ... Siltuximab #COVID19 #Pharmacology ... #Management #Medications
IDSA Recommendations for Preventing and Managing Microsporidiosis in HIV-AIDS
Preventing Chronic Microsporidiosis:
 • Because chronic microsporidiosis occurs
Gastrointestinal Infections ... available for this infection ... Prevention #Treatment #management ... opportunistic #infections ... #HIVAIDS #pharmacology